SEC Form 4 · accession 0001209191-17-005557
ALBIREO PHARMA, INC. · ALBO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Davey Scoon
Director
Period of report
Jan 23, 2017
Accepted (ET)
Jan 25, 2017 · 5:26 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001322505
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $18.54 | Jan 23, 2017 | A | 4,500 | A | — | Jan 22, 2027 | Common Stock | 4,500 | 4,500 | D |
Explanation of responses
- F1This option will vest and become exercisable in equal annual installments on the first three anniversaries of the date of grant (but, in any case, to be fully vested on the day prior to the annual meeting for the third fiscal year that begins following the date of grant).
Remarks
Exhibit 24.1 - Power of Attorney